China’s Nature Weapon


Byron Rios, Junior

At the time of January 2016, James Clapper, the U.S. Director of National Intelligence, arranged a briefing discussing the abundance of threats that were being directed towards the United States. 

 To the surprise of many, Clapper spent most of his time discussing the birth of a new exotic threat: Biomedical Research. During the briefing, Clapper states: “Research in genome editing conducted by countries with different regulatory or ethical standards than those of Western countries probably increases the risk of the creation of potentially harmful biological agents or products.”

Clapper’s fear is that the manipulation and editing of DNA by countries who have different ideals and ethics from western countries can result in the creation of harmful biological agents.

During the 20th century, the United States and the Soviet Union held the world at a potential catastrophe with its nuclear power. Now in the 21st century, China and the United States are the main players in having the potential to create a planetary crisis.

China’s ability to become a positive biomedical central powerhouse should motivate Xi Jinping (General Secretary of China’s Communist Party) in funding China’s National Research Facility. 

On the other hand, the fact that a non-Western country or power is creating a biological agent or product, should be taken as a threat to the United States.

 A leading American geneticist, Harris Lewin, warns that the United States is “starting to fall behind … the Chinese, who have always been good collaborators, [are] now taking the lead.” 

It has recently been released to the public that on November 27 of 2018, the research institution in Shanghai has successfully cloned five baby primate macaques (a type of monkey).

This accomplishment has opened the doors to China’s new ability in Biomedical Engineering and because of China’s unrestricted barriers regarding Biomedical research, it pushes America farther back in its attempt to catch up to China’s newfound power.